Physician profile
David Lin
NPI 1649537838
$1,358.22
in general payments reported to CMS, 2019-2025
15 companies · $271 in 2025
The $271 reported for 2025 was more than what 85% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.42 · 2020: $21.20 · 2021: $62.36 · 2022: $520 · 2023: $173 · 2024: $300 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $292.61 | 2023-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Synergy Ablation System |
| Abiomed | $289.81 | 2022-2025 | Impella |
| Abbott Laboratories | $176.58 | 2024 | Navitor |
| Heron Therapeutics, INC. | $121.91 | 2022 | |
| Acacia Pharma INC | $120.98 | 2022 | |
| Trevena, INC. | $97.22 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.54 | 2022-2023 | Trulance, Xifaxan |
| Edwards Lifesciences Corporation | $35.77 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $26.75 | 2019-2021 | |
| Abbvie INC. | $23.93 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $23.43 | 2022 | |
| Janssen Biotech, INC. | $23.10 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $22.32 | 2023 | Dupixent |
| Mallinckrodt Hospital Products INC. | $21.20 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $19.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.